Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MN7

Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment

Summary for 6MN7
Entry DOI10.2210/pdb6mn7/pdb
EMDB information9166
DescriptorEnvelope Glycoprotein gp120, 2-acetamido-2-deoxy-beta-D-glucopyranose, Envelope Glycoprotein gp41, ... (10 entities in total)
Functional Keywordsviral protein, complex, broadly neutralizing antibody
Biological sourceHuman immunodeficiency virus 1
More
Total number of polymer chains9
Total formula weight325967.90
Authors
Williams, J.A.,Lee, K.K.,Overbaugh, J. (deposition date: 2018-10-01, release date: 2019-03-06, Last modification date: 2020-07-29)
Primary citationSimonich, C.A.,Doepker, L.,Ralph, D.,Williams, J.A.,Dhar, A.,Yaffe, Z.,Gentles, L.,Small, C.T.,Oliver, B.,Vigdorovich, V.,Mangala Prasad, V.,Nduati, R.,Sather, D.N.,Lee, K.K.,Matsen Iv, F.A.,Overbaugh, J.
Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage.
Nat Commun, 10:2190-2190, 2019
Cited by
PubMed Abstract: HIV-infected infants develop broadly neutralizing plasma responses with more rapid kinetics than adults, suggesting the ontogeny of infant responses could better inform a path to achievable vaccine targets. Here we reconstruct the developmental lineage of BF520.1, an infant-derived HIV-specific broadly neutralizing antibody (bnAb), using computational methods developed specifically for this purpose. We find that the BF520.1 inferred naive precursor binds HIV Env. We also show that heterologous cross-clade neutralizing activity evolved in the infant within six months of infection and that, ultimately, only 2% SHM is needed to achieve the full breadth of the mature antibody. Mutagenesis and structural analyses reveal that, for this infant bnAb, substitutions in the kappa chain were critical for activity, particularly in CDRL1. Overall, the developmental pathway of this infant antibody includes features distinct from adult antibodies, including several that may be amenable to better vaccine responses.
PubMed: 31097697
DOI: 10.1038/s41467-019-09481-7
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (4.8 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon